Rad AI is now also transforming patient follow-up with Rad AI Continuity by closing the loop on actionable findings in radiology reports – most commonly, potential new cancers. Using AI-driven automation, Rad AI Continuity helps ensure that patients are diagnosed and treated promptly. To date, Rad AI has increased follow-up rates at health systems from 30 percent up to 75 percent or more[4], leading to earlier diagnoses of new cancers to help ensure patients receive prompt treatment, improving long-term prognosis and quality of life.

"At Rad AI, we focus on empowering physicians with AI – saving physicians time, reducing burnout and improving the quality of patient care," said Doktor Gurson, co-founder and CEO at Rad AI. "Over the past few years, Rad AI has become a mission-critical part of physician and health system workflows across North America. This strategic funding round will accelerate our progress as the leading AI-driven workflow platform in healthcare."


Rad AI is now hiring across a wide range of roles, building a world-class team dedicated to solving some of the most complex challenges in healthcare technology.

About Rad AI
Rad AI is the leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company's flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company's pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of US radiologists. Rad AI Continuity, the most comprehensive solution of its kind, uses AI to help ensure patient follow-up for potential new cancers.

Back to HCB News

US Press Room Homepage